289 related articles for article (PubMed ID: 37025486)
1. Epigallocatechin gallate alleviates high-fat diet-induced hepatic lipotoxicity by targeting mitochondrial ROS-mediated ferroptosis.
Ding SB; Chu XL; Jin YX; Jiang JJ; Zhao X; Yu M
Front Pharmacol; 2023; 14():1148814. PubMed ID: 37025486
[No Abstract] [Full Text] [Related]
2. Targeting Mitochondrial ROS-Mediated Ferroptosis by Quercetin Alleviates High-Fat Diet-Induced Hepatic Lipotoxicity.
Jiang JJ; Zhang GF; Zheng JY; Sun JH; Ding SB
Front Pharmacol; 2022; 13():876550. PubMed ID: 35496312
[No Abstract] [Full Text] [Related]
3. Epigallocatechin-3-Gallate Alleviates Liver Oxidative Damage Caused by Iron Overload in Mice through Inhibiting Ferroptosis.
Yang C; Wu A; Tan L; Tang D; Chen W; Lai X; Gu K; Chen J; Chen D; Tang Q
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111212
[TBL] [Abstract][Full Text] [Related]
4. Ambient particulate matter exposure plus chronic ethanol ingestion exacerbates hepatic fibrosis by triggering the mitochondrial ROS-ferroptosis signaling pathway in mice.
Ding S; Jiang J; Zhang G; Yu M; Zheng Y
Ecotoxicol Environ Saf; 2023 May; 256():114897. PubMed ID: 37043943
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization.
Du Y; Paglicawan L; Soomro S; Abunofal O; Baig S; Vanarsa K; Hicks J; Mohan C
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33670347
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways.
Xiao J; Ho CT; Liong EC; Nanji AA; Leung TM; Lau TY; Fung ML; Tipoe GL
Eur J Nutr; 2014 Feb; 53(1):187-99. PubMed ID: 23515587
[TBL] [Abstract][Full Text] [Related]
7. Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice.
Ushiroda C; Naito Y; Takagi T; Uchiyama K; Mizushima K; Higashimura Y; Yasukawa Z; Okubo T; Inoue R; Honda A; Matsuzaki Y; Itoh Y
J Clin Biochem Nutr; 2019 Jul; 65(1):34-46. PubMed ID: 31379412
[TBL] [Abstract][Full Text] [Related]
8. Green tea polyphenol epigallocatechin-3-gallate alleviates nonalcoholic fatty liver disease and ameliorates intestinal immunity in mice fed a high-fat diet.
Huang J; Li W; Liao W; Hao Q; Tang D; Wang D; Wang Y; Ge G
Food Funct; 2020 Nov; 11(11):9924-9935. PubMed ID: 33095225
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin gallate alleviates non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4.
Yang M; Yan R; Sha R; Wang X; Zhou S; Li B; Zheng Q; Cao Y
Clin Nutr; 2024 Jun; 43(8):1769-1780. PubMed ID: 38936303
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21-AMPK pathway in mice fed a high fat diet.
Zhang Y; Yin R; Lang J; Fu Y; Yang L; Zhao D
Diabetol Metab Syndr; 2022 Apr; 14(1):53. PubMed ID: 35418153
[TBL] [Abstract][Full Text] [Related]
11. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice.
Gan L; Meng ZJ; Xiong RB; Guo JQ; Lu XC; Zheng ZW; Deng YP; Luo BD; Zou F; Li H
Acta Pharmacol Sin; 2015 May; 36(5):597-605. PubMed ID: 25891086
[TBL] [Abstract][Full Text] [Related]
12. Theaphenon E prevents fatty liver disease and increases CD4+ T cell survival in mice fed a high-fat diet.
Coia H; Ma N; Hou Y; Permaul E; Berry DL; Cruz MI; Pannkuk E; Girgis M; Zhu Z; Lee Y; Rodriquez O; Cheema A; Chung FL
Clin Nutr; 2021 Jan; 40(1):110-119. PubMed ID: 32439267
[TBL] [Abstract][Full Text] [Related]
13. Targeting ferroptosis alleviates methionine-choline deficient (MCD)-diet induced NASH by suppressing liver lipotoxicity.
Li X; Wang TX; Huang X; Li Y; Sun T; Zang S; Guan KL; Xiong Y; Liu J; Yuan HX
Liver Int; 2020 Jun; 40(6):1378-1394. PubMed ID: 32145145
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via Inhibition of Apoptosis and Promotion of Autophagy through the ROS/MAPK Signaling Pathway.
Wu D; Liu Z; Wang Y; Zhang Q; Li J; Zhong P; Xie Z; Ji A; Li Y
Oxid Med Cell Longev; 2021; 2021():5599997. PubMed ID: 33953830
[TBL] [Abstract][Full Text] [Related]
15. The natural flavone acacetin protects against high-fat diet-induced lipid accumulation in the liver via the endoplasmic reticulum stress/ferroptosis pathway.
Jiang Z; Sun H; Miao J; Sheng Q; Xu J; Gao Z; Zhang X; Song Y; Chen K
Biochem Biophys Res Commun; 2023 Jan; 640():183-191. PubMed ID: 36516527
[TBL] [Abstract][Full Text] [Related]
16. Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism.
Tang G; Xu Y; Zhang C; Wang N; Li H; Feng Y
Antioxidants (Basel); 2021 Jul; 10(7):. PubMed ID: 34356308
[TBL] [Abstract][Full Text] [Related]
17. (-)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitis.
Sumi T; Shirakami Y; Shimizu M; Kochi T; Ohno T; Kubota M; Shiraki M; Tsurumi H; Tanaka T; Moriwaki H
Springerplus; 2013; 2():690. PubMed ID: 25674420
[TBL] [Abstract][Full Text] [Related]
18. Hepatoprotective effects and mechanisms of l-theanine and epigallocatechin gallate combined intervention in alcoholic fatty liver rats.
Xu KH; Yang DF; Liu MY; Xu W; Li YH; Xiao WJ
J Sci Food Agric; 2024 Jun; ():. PubMed ID: 38873964
[TBL] [Abstract][Full Text] [Related]
19. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice.
Bose M; Lambert JD; Ju J; Reuhl KR; Shapses SA; Yang CS
J Nutr; 2008 Sep; 138(9):1677-83. PubMed ID: 18716169
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-Gallate-Rich Green Tea Extract Ameliorates Fatty Liver and Weight Gain in Mice Fed a High Fat Diet by Activating the Sirtuin 1 and AMP Activating Protein Kinase Pathway.
Bae UJ; Park J; Park IW; Chae BM; Oh MR; Jung SJ; Ryu GS; Chae SW; Park BH
Am J Chin Med; 2018; 46(3):617-632. PubMed ID: 29595075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
